MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

Long-term survival in oesophageal squamous cell carcinoma (ESCC) is related with pathological response after neoadjuvant chemoradiotherapy (NCRT) followed by surgery. However, effective biomarkers to predict the pathologic response are still lacking. Therefore, a systematic analysis focusing on gene...

Full description

Bibliographic Details
Main Authors:	Qiyu Luo, Wenwu He, Tianqin Mao, Xuefeng Leng, Hong Wu, Wen Li, Xuyang Deng, Tingci Zhao, Ming Shi, Chuan Xu, Yongtao Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Oncology
Subjects:	oesophageal squamous cell carcinoma MMS22L bioinformatics analysis neoadjuvant chemoradiotherapy lymph node metastasis migration
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.711642/full

Similar Items

PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma
by: Edge, S.D., et al.
Published: (2021)

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
by: Bo Jan Noordman, et al.
Published: (2018-02-01)

Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
by: Ben M. Eyck, et al.
Published: (2021-05-01)

Minimally invasive oesophagectomy with a total two-field lymphadenectomy after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of the oesophagus: A prospective study
by: Kuppusamy Sasikumar, et al.
Published: (2021-01-01)

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)
by: Hai-Bo Sun, et al.
Published: (2020-04-01)

Clinical Outcomes and Prognostic Factors of Salvage Treatment for Local Lymph Node Recurrence After Radical Resection of Oesophageal Carcinoma
by: Gu L, et al.
Published: (2021-07-01)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
by: Hyehyun Jeong, et al.
Published: (2021-03-01)

“Sentinel lymph node imaging with sequential SPECT/CT lymphoscintigraphy before and after neoadjuvant chemoradiotherapy in patients with cancer of the oesophagus or gastro-oesophageal junction – a pilot study”
by: Stefan Gabrielson, et al.
Published: (2018-12-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Mms1 & Mms22 Mediate Genome Stability in Saccharomyces cerevisiae
by: Vaisica, Jessica Anne
Published: (2012)

Mms1 & Mms22 Mediate Genome Stability in Saccharomyces cerevisiae
by: Vaisica, Jessica Anne
Published: (2012)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Efficacy of modified neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A single institution experience in Taiwan
by: Yi-Ying Wu, et al.
Published: (2014-01-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Ding T, et al.
Published: (2021-10-01)

The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal Cancer
by: Yiqiang Liu, et al.
Published: (2021-05-01)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
by: Yang Yang, et al.
Published: (2020-08-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Yaqi Wang, et al.
Published: (2019-08-01)

Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model
by: Jie Kong, et al.
Published: (2021-09-01)

Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: XIONG Kai, et al.
Published: (2021-01-01)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)

Neoadjuvant Radiotherapy/Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
by: Deniz Yalman
Published: (2015-03-01)

Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy
by: Ke-Jie Li, et al.
Published: (2019-10-01)

What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta‐analysis and systematic review
by: Xuyang Yang, et al.
Published: (2020-07-01)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
by: Ali Kermani, et al.
Published: (2020-01-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari Chiara, et al.
Published: (2011-11-01)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
by: Song J, et al.
Published: (2020-08-01)

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-07-01)

Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
by: Dong-Bin Wang, et al.
Published: (2016-01-01)

Preoperative chemoradiotherapy for locally advanced gastric cancer
by: Pepek Joseph M, et al.
Published: (2013-01-01)

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)
by: Hai-Yu Zhou, et al.
Published: (2020-07-01)

Is Margin Status Less Prognostic After Neoadjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma?
by: Callery, M.P, et al.
Published: (2022)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01)

Construction of the Prediction Model for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy Based on Pretreatment Tumor-Infiltrating Macrophage-Associated Biomarkers
by: Liu X, et al.
Published: (2021-04-01)

Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy
by: Mingrui Shao, et al.
Published: (2019-03-01)

Combined Therapy of Locally Advanced Oesophageal and Gastro–Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors
by: Milan Vošmik, et al.
Published: (2021-09-01)

Is long interval from neoadjuvant chemoradiotherapy to surgery optimal for rectal cancer in the era of intensity-modulated radiotherapy?: a prospective observational study
by: Chang H, et al.
Published: (2018-09-01)

Prognostic Impact of Pretreatment Elevated and Normalized Carcinoembryonic Antigen Levels After Neoadjuvant Chemoradiotherapy in Resected Locally Advanced Rectal Cancer Patients
by: Song J, et al.
Published: (2021-05-01)

Cannot write session to /tmp/vufind_sessions/sess_m90dc0likamplb8koadjmuhvmv